Talk:Tiotropium bromide: Difference between revisions

Content deleted Content added

Inline

Revision as of 16:00, 24 August 2009

This is the talk page for discussing improvements to the Tiotropium bromide article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Pharmacology Start‑class High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Start	This article has been rated as Start-class on Wikipedia's content assessment scale.
High	This article has been rated as High-importance on the project's importance scale.

I deleted some dead links in the External Link section. Added in hopefully some better links. RonEJ 19:05, 17 March 2007 (UTC)[reply]

I have a scanned picture available for use.

File:SP2.png

RonEJ 13:24, 19 March 2007 (UTC)[reply]

Poorly Written Article

The section on medication administration was extremely poorly written - it was as if someone tried to translate the patient information leaflet from another language into English. I have extensively re-written this section, and have de-emphasised the terms "Tiotropium Bromide" and "Spiriva" in the introduction.

Russthomas1515 (talk) 05:17, 29 March 2008 (UTC)[reply]

Asthma

The Asthma Research Center at Brigham and Women's Hospital is conducting a study (Genotype Stratified Treatment With Anticholinergic vs. Beta-Agonist (Long Acting) and Exacerbations (GABLE)) that involves certain asthmatics (based on results from a blood test) taking Spiriva instead of Advair or Symbicort. The ClinicalTrials.gov identifier for this study is: NCT00706446. I signed up for the research study; my first visit is tomorrow. -- Christopher C. Parker ^{t c} 21:48, 18 August 2009 (UTC)[reply]

@@ Line 19: / Line 19: @@
 [[User:Russthomas1515|Russthomas1515]] ([[User talk:Russthomas1515|talk]]) 05:17, 29 March 2008 (UTC)
-== Asthma, too ==
+== Asthma ==
+The [http://www.asthmabwh.org/ Asthma Research Center] at [[Brigham and Women's Hospital]] is conducting a study (Genotype Stratified Treatment With Anticholinergic vs. Beta-Agonist (Long Acting) and Exacerbations (GABLE)) that involves certain asthmatics (based on results from a blood test) taking Spiriva instead of [[Advair]] or [[Symbicort]]. The ClinicalTrials.gov identifier for this study is: [http://clinicaltrials.gov/ct2/show/NCT00706446 NCT00706446]. I signed up for the research study; my first visit is tomorrow. -- [[User:cparker|Christopher C. Parker]] <sup>[[User talk:cparker|t]] [[Special:Contributions/cparker|c]]</sup> 21:48, 18 August 2009 (UTC)
-While usually used to treat COPD symptoms (the drug information page at the FDA [http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm107272.htm] only lists COPD), it should be noted that Spiriva can also be used to treat asthma symptoms, and is approved by the FDA as such. From an FDA advisory from last year ([http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm051132.html]):
-:Spiriva and Foradil capsules are to be used in the HandiHaler (Spiriva) and Aerolizer (Foradil) devices to deliver the medicine to the lungs to improve breathing in patients with asthma, and in individuals affected by chronic obstructive lung disease (COPD), including chronic bronchitis and emphysema.
-Also of note: The [http://www.asthmabwh.org/ Asthma Research Center] at [[Brigham and Women's Hospital]] is conducting a study (Genotype Stratified Treatment With Anticholinergic vs. Beta-Agonist (Long Acting) and Exacerbations (GABLE)) that involves certain asthmatics (based on results from a blood test) taking Spiriva instead of [[Advair]] or [[Symbicort]]. The ClinicalTrials.gov identifier for this study is: [http://clinicaltrials.gov/ct2/show/NCT00706446 NCT00706446]. I signed up for the research study; my first visit is tomorrow. -- [[User:cparker|Christopher C. Parker]] <sup>[[User talk:cparker|t]] [[Special:Contributions/cparker|c]]</sup> 21:48, 18 August 2009 (UTC)